Efficacy and safety of transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors in the treatment of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Junning Liu, Song Wei, Linfeng Yang, Jiahui Yu, Yan Duan, Pengsheng Yi
Topics & Concepts
MedicineLenvatinibInternal medicineHazard ratioHepatocellular carcinomaGastroenterologyRelative riskMeta-analysisAdverse effectConfidence intervalCochrane LibraryOncologySorafenibHepatocellular Carcinoma Treatment and PrognosisSilymarin and Mushroom PoisoningCholangiocarcinoma and Gallbladder Cancer Studies